PI
XBI icon

PEAK6 Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PEAK6 Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$95.4M Buy
965,200
+521,700
+118% +$51.3M 0.21% 87
2024
Q2 		$41.1M Buy
443,500
+99,300
+29% +$8.9M 0.11% 147
2024
Q1 		$32.7M Buy
344,200
+11,800
+4% +$1.09M 0.09% 189
2023
Q4 		$29.7M Sell
332,400
-88,500
-21% -$6.57M 0.11% 148
2023
Q3 		$30.7M Buy
420,900
+213,600
+103% +$17.1M 0.14% 107
2023
Q2 		$17.2M Sell
207,300
-259,400
-56% -$21.7M 0.08% 220
2023
Q1 		$35.6M Buy
466,700
+196,400
+73% +$16.3M 0.17% 95
2022
Q4 		$22.4M Buy
270,300
+133,600
+98% +$10.8M 0.13% 146
2022
Q3 		$10.8M Sell
136,700
-281,600
-67% -$23.7M 0.05% 411
2022
Q2 		$32.9M Buy
418,300
+78,800
+23% +$5.92M 0.06% 291
2022
Q1 		$30.5M Sell
339,500
-28,500
-8% -$2.63M 0.07% 276
2021
Q4 		$41.2M Sell
368,000
-365,500
-50% -$44.1M 0.09% 213
2021
Q3 		$92.2M Buy
733,500
+10,000
+1% +$1.29M 0.21% 75
2021
Q2 		$98M Sell
723,500
-140,000
-16% -$18.4M 0.23% 69
2021
Q1 		$117M Buy
863,500
+18,100
+2% +$2.71M 0.28% 52
2020
Q4 		$119M Sell
845,400
-70,000
-8% -$8.97M 0.25% 63
2020
Q3 		$102M Sell
915,400
-40,000
-4% -$4.48M 0.25% 66
2020
Q2 		$107M Sell
955,400
-998,500
-51% -$98.3M 0.37% 44
2020
Q1 		$107M Buy
1,953,900
+1,206,200
+161% +$107M 0.63% 23
2019
Q4 		$71.1M Buy
747,700
+99,200
+15% +$8.58M 0.37% 46
2019
Q3 		$49.4M Buy
648,500
+163,100
+34% +$13.6M 0.31% 43
2019
Q2 		$42.6M Buy
485,400
+93,400
+24% +$7.97M 0.28% 45
2019
Q1 		$35.5M Sell
392,000
-201,200
-34% -$17.1M 0.21% 85
2018
Q4 		$42.6M Buy
593,200
+50,600
+9% +$4.08M 0.27% 50
2018
Q3 		$52M Buy
+542,600
New +$52.6M 0.23% 67

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

PEAK6 Investments's XBI Position: Q1 2024 in Review

PEAK6 Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2024, closing a stake of 12,756 shares — an estimated $1.18M sold.

PEAK6 Investments first reported a position in XBI in Q1 2020 and held it in 7 quarters. The position peaked at $27.6M in Q1 2022. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

  • PEAK6 Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 12,756 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $1.18M.
  • PEAK6 Investments first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 7 quarters.
  • PEAK6 Investments's State Street SPDR S&P Biotech ETF position peaked at $27.6M in Q1 2022.
  • 780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.